The antimalarial activity of N-benzyloxydihydrotriazines. II. The development of resistance to clociguanil (BRL 50216) and cycloguanil by P. berghei.
D000818:Animals; D000962:Antimalarials / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004352:Drug Resistance, Microbial; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D051379:Mice; D010962:Plasmodium berghei / Q000187:drug effects; D014227:Triazines / Q000627:therapeutic use*; D014774:Virulence
D000962:Antimalarials; D014227:Triazines; C007087:clociguanil